These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33914772)

  • 21. Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves' Disease From Autoimmune Thyroiditis.
    Wu Z; Zhu Y; Zhang M; Wang C; Zhou L; Liu W; Yang W; Li M; Zhang S; Ren Q; Han X; Ji L
    Front Endocrinol (Lausanne); 2020; 11():620407. PubMed ID: 33488527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. fT3:fT4 ratio in Graves' disease - correlation with TRAb level, goiter size and age of onset.
    Minasyan M; Dulęba A; Smalarz A; Stręk M; Bryniarski P; Przybylik-Mazurek E; Hubalewska-Dydejczyk A
    Folia Med Cracov; 2020 Sep; 60(2):15-27. PubMed ID: 33252592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
    Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves' disease during long-term treatment period].
    Komaki T; Sakata S; Nakamura S; Matsuda M; Kojima N; Takuno H; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1989 Jul; 65(7):627-39. PubMed ID: 2583311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease.
    Ito M; Kawasaki M; Danno H; Kohsaka K; Nakamura T; Hisakado M; Yoshioka W; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Nakamura H; Miyauchi A
    Thyroid; 2019 Oct; 29(10):1364-1370. PubMed ID: 31411123
    [No Abstract]   [Full Text] [Related]  

  • 26. GENDER INFLUENCES THE CLINICAL PRESENTATION AND LONG-TERM OUTCOME OF GRAVES DISEASE.
    Magri F; Zerbini F; Gaiti M; Capelli V; Ragni A; Rotondi M; Chiovato L
    Endocr Pract; 2016 Nov; 22(11):1336-1342. PubMed ID: 27540885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid hormones, their carrier proteins, and thyroid antibodies in the pleural effusion of two patients with graves' disease-induced thyrotoxicosis.
    Kinoshita H; Yasuda M; Kaneko S; Usui R; Inoshita S; Furumoto Y; Maruyama Y; Susa K; Suenaga M; Fujita H; Tomiyama J; Yakushiji F
    Endocr Res; 2010; 35(4):183-7. PubMed ID: 20868289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid Hormone Status in Overweight Children with Attention Deficit/Hyperactivity Disorder.
    Langrock C; Hebebrand J; Radowksi K; Hamelmann E; Lücke T; Holtmann M; Legenbauer T; Schmidt B; Frank M; Jöckel KH; Reinehr T
    Horm Res Paediatr; 2018; 89(3):150-156. PubMed ID: 29320782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
    Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiating Graves' disease from subacute thyroiditis using ratio of serum free triiodothyronine to free thyroxine.
    Sriphrapradang C; Bhasipol A
    Ann Med Surg (Lond); 2016 Sep; 10():69-72. PubMed ID: 27570620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis.
    Izumi Y; Hidaka Y; Tada H; Takano T; Kashiwai T; Tatsumi KI; Ichihara K; Amino N
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):51-8. PubMed ID: 12100069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triiodothyronine-predominant Graves' disease in childhood: detection and therapeutic implications.
    Harvengt J; Boizeau P; Chevenne D; Zenaty D; Paulsen A; Simon D; Guilmin Crepon S; Alberti C; Carel JC; Léger J
    Eur J Endocrinol; 2015 Jun; 172(6):715-23. PubMed ID: 25766047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The clinical and laboratory findings in Graves' multinodular type disease].
    Grammaticos P; Vasiliou O; Papanastasiou E; Gerasimou G; Balaris V; Alexandris R; Liaros G; Dedousi E
    Hell J Nucl Med; 2006; 9(1):53-9. PubMed ID: 16617399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No association between affective and behavioral dysregulation and parameters of thyroid function in youths.
    Zepf FD; Vloet TD; Polier GG; Baurmann D; Bubenzer S; Helmbold K; Gaber TJ; Schmidt T; Herpertz-Dahlmann B; Wöckel L
    J Affect Disord; 2011 Nov; 134(1-3):478-82. PubMed ID: 21715014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease.
    Bogazzi F; Bartalena L; Campomori A; Brogioni S; Traino C; De Martino F; Rossi G; Lippi F; Pinchera A; Martino E
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4490-5. PubMed ID: 12364424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex-specific Effect of Maternal Thyroid Hormone Trajectories on Preschoolers' Behavioral Development: A Birth Cohort Study.
    Li P; Teng Y; Ru X; Liu Z; Han Y; Tao F; Huang K
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2037-e2046. PubMed ID: 34999790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. General properties of autoimmune thyroid diseases and associated morbidities.
    Ibili ABP; Selver Eklioglu B; Atabek ME
    J Pediatr Endocrinol Metab; 2020 Apr; 33(4):509-515. PubMed ID: 32126013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease.
    Ota H; Amino N; Morita S; Kobayashi K; Kubota S; Fukata S; Kamiyama N; Miyauchi A
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):41-5. PubMed ID: 17437515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study.
    Pearce SHS; Dayan C; Wraith DC; Barrell K; Olive N; Jansson L; Walker-Smith T; Carnegie C; Martin KF; Boelaert K; Gilbert J; Higham CE; Muller I; Murray RD; Perros P; Razvi S; Vaidya B; Wernig F; Kahaly GJ
    Thyroid; 2019 Jul; 29(7):1003-1011. PubMed ID: 31194638
    [No Abstract]   [Full Text] [Related]  

  • 40. Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow.
    Ide A; Amino N; Kang S; Yoshioka W; Kudo T; Nishihara E; Ito M; Nakamura H; Miyauchi A
    Thyroid; 2014 Jun; 24(6):1027-31. PubMed ID: 24400892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.